We are live on !
Find out more
Loeb Partners Corp Portfolio holdings
AUM
$4.86M
Turnover
54.46%
1-Year Est. Return
7.22%
This Fund
S&P 500
This Quarter Est. Return
+13.67%
1 Year Est. Return
+7.22%
3 Year Est. Return
+34.39%
5 Year Est. Return
+90.55%
10 Year Est. Return
–
AUM
$4.86M
AUM Growth
-$210M
(-98%)
Cap. Flow
-$220M
Cap. Flow % of AUM
Cap. Flow %
-4,519.26%
Top 10 Holdings %
Top 10 Hldgs %
46.43%
Holding
336
New
4
Increased
3
Reduced
95
Closed
179
Avg Time Held
1.2
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$32.5K |
| 2 |
Cisco
CSCO
|
+$21.9K |
| 3 |
Moderna
MRNA
|
+$14.8K |
| 4 |
Alexandria Real Estate Equities
ARE
|
+$6.58K |
| 5 |
Nektar Therapeutics
NKTR
|
+$5.93K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$9.9M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$9.9M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$9.39M |
| 4 |
Bank of New York Mellon
BNY
|
+$8M |
| 5 |
Diageo
DEO
|
+$7.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.3% |
| 2 | Technology | 22.52% |
| 3 | Financials | 13.63% |
| 4 | Communication Services | 8.88% |
| 5 | Consumer Staples | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
DELISTED
TEGNA Inc
TGNA
| $12K | 0.25% |
800
-600
| -43% | -$7.62K |
2018 Q4
1 quarter
|
|
77
ExxonMobil
XOM
$753B
| $12K | 0.25% |
150
-50,328
| -100% | -$3.84M |
2013 Q2
23 quarters
|
|
78
American Homes 4 Rent
AMH
$11.5B
| $11K | 0.23% |
500
-186,629
| -100% | -$4.09M |
2014 Q2
19 quarters
|
|
79
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.68B
| $11K | 0.23% |
1,278
| – | – |
2018 Q4
1 quarter
|
|
80
Vornado Realty Trust
VNO
$6.5B
| $11K | 0.23% |
160
-50,220
| -100% | -$3.37M |
2016 Q3
10 quarters
|
|
81
NovoCure
NVCR
$1.71B
| $10K | 0.21% |
200
| – | – |
2018 Q4
1 quarter
|
|
82
Resideo Technologies
REZI
$2.71B
| $10K | 0.21% |
500
-566
| -53% | -$12.5K |
2018 Q4
1 quarter
|
|
83
Gabelli Multimedia Trust
GGT
$166M
| $9K | 0.19% |
1,042
| – | – |
2018 Q4
1 quarter
|
|
84
PIMCO High Income Fund
PHK
$760M
| $9K | 0.19% |
1,000
-500
| -33% | -$4.34K |
2018 Q4
1 quarter
|
|
85
PIMCO Municipal Income Fund II
PML
$451M
| $9K | 0.19% |
600
| – | – |
2018 Q4
1 quarter
|
|
|
RTN
86
DELISTED
Raytheon Company
RTN
| $9K | 0.19% |
50
| – | – |
2018 Q4
1 quarter
|
|
87
abrdn Emerging Markets Equity Income Fund
AEF
$338M
| $8K | 0.16% |
1,084
-361
| -25% | -$2.55K |
2018 Q4
1 quarter
|
|
88
GE Aerospace
GE
$296B
| $8K | 0.16% |
171
-48
| -22% | -$2.26K |
2018 Q4
1 quarter
|
|
|
BTA
89
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
| $7K | 0.14% |
600
| – | – |
2018 Q4
1 quarter
|
|
90
PIMCO Corporate & Income Opportunity Fund
PTY
$2.37B
| $7K | 0.14% |
400
| – | – |
2018 Q4
1 quarter
|
|
91
State Street Technology Select Sector SPDR ETF
XLK
$121B
| $7K | 0.14% |
200
-30,000
| -99% | -$1.03M |
2018 Q2
3 quarters
|
|
92
Broadridge
BR
$20.7B
| $6K | 0.12% |
50
-25
| -33% | -$2.51K |
2018 Q4
1 quarter
|
|
93
Citigroup
C
$202B
| $6K | 0.12% |
99
| – | – |
2018 Q2
3 quarters
|
|
|
94
Nektar Therapeutics
NKTR
$1.27B
| $6K | 0.12% |
13
+10
| +333% | +$5.93K |
2018 Q4
1 quarter
|
|
95
Wells Fargo
WFC
$247B
| $6K | 0.12% |
121
-49
| -29% | -$2.41K |
2018 Q4
1 quarter
|
|
96
Ameriprise Financial
AMP
$43.5B
| $5K | 0.1% |
40
| – | – |
2018 Q4
1 quarter
|
|
97
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $5K | 0.1% |
80
-27
| -25% | -$1.54K |
2018 Q4
1 quarter
|
|
98
Evercore
EVR
$9.7B
| $5K | 0.1% |
50
| – | – |
2018 Q4
1 quarter
|
|
99
Lam Research
LRCX
$288B
| $5K | 0.1% |
300
| – | – |
2018 Q4
1 quarter
|
|
100
Rigel Pharmaceuticals
RIGL
$899M
| $5K | 0.1% |
200
| – | – |
2018 Q4
1 quarter
|
|
Similar funds
CCM
Loeb Partners Corp's Q1 2019 Portfolio in Review
As of Q1 2019, Loeb Partners Corp held 336 positions worth $4.86M, down 98% from $215M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Loeb Partners Corp withdrew a net $220M in Q1 2019, closing 179 positions and reducing 95 holdings. Its most notable exit was iShares S&P 500 Value ETF, an estimated $4.55M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 6.3% a quarter earlier, followed by Technology and Financials.
Against the trend, Loeb Partners Corp opened a new position in Unilever worth $36K.
- Loeb Partners Corp's largest Q1 2019 buy was Unilever: 533 shares worth $36K.
- Loeb Partners Corp added most to Cisco in Q1 2019, an estimated $21.9K increase.
- Loeb Partners Corp's biggest Q1 2019 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $9.9M.
- Loeb Partners Corp fully exited iShares S&P 500 Value ETF in Q1 2019, selling an estimated $4.55M.
- Loeb Partners Corp's ten largest holdings make up 46% of its $4.86M portfolio in Q1 2019.
- Loeb Partners Corp opened 4 new positions and closed 179 in Q1 2019.
- Loeb Partners Corp's portfolio value fell 98% quarter-over-quarter to $4.86M.
Based on Loeb Partners Corp's 13F filing for Q1 2019, filed 14 May 2019.